Consistently, the presence of functional NRF2 binding sites within the AREs of the TKT promoter was also reported in MEFs and A549 NSCLC cells, suggesting a direct transactivation mechanism [240]. Here, NFE2L2 is linked to non-small cell lung carcinoma.